Overexpression of PAK1 has been correlated with NSCLC [25], breast cancer, prostate cancer [26], pancreatic cancer, gastric cancer [27,28], colorectal carcinoma [29], and oral cancers [30]. Here, PAK1 is linked to breast carcinoma.